Moderator: Mark Lovern, PhD (he/him/his) – InSilicoTrials
### he/him/his @@@ Jared Weddell, PhD – Astellas ### 2363735###Speaker###Modeling and Simulation Scientist###Astellas###Speaker: Jared Weddell, PhD – Astellas
### @@@ Hardik Mody, PhD (he/him/his) – Genentech ### 2363736###Speaker###Principal Scientist, Clinical Pharmacology###Genentech###Speaker: Hardik Mody, PhD (he/him/his) – Genentech
### he/him/his @@@ Ahmed Abdelhady Abozeid, PhD (he/him/his) – Intellia ### 2407052###Speaker###Clinical Pharmacology Director###Intellia###Speaker: Ahmed Abdelhady Abozeid, PhD (he/him/his) – Intellia
### he/him/hisChair: Martin Bergstrand, PhD, ISOP member (he/him/his) – Pharmetheus AB
### he/him/his @@@ Pavan Vaddady, PhD – Merck & Co., Inc. ### 2360679###Chair###Executive Director, QP2 Oncology###Merck & Co., Inc.###Chair: Pavan Vaddady, PhD – Merck & Co., Inc.
### @@@ Tushar Garimella, PhD, ISoP member, ACCP member (he/him/his) – Daiichi Sankyo Inc ### 2360681###Speaker###Executive Director, Quantitative Clinical Pharmacology###Daiichi Sankyo Inc###Speaker: Tushar Garimella, PhD, ISoP member, ACCP member (he/him/his) – Daiichi Sankyo Inc
### he/him/his @@@ Andrew C. Hooker, PhD, ISOP member – Uppsala University ### 2360680###Speaker###Professor of Pharmacometrics###Uppsala University###Speaker: Andrew C. Hooker, PhD, ISOP member – Uppsala University
### @@@ Antoine Pitoy, PhD student – INSERM / Université Paris Cité ### 2408243###Speaker###PhD Student###INSERM / Université Paris Cité ###Speaker: Antoine Pitoy, PhD student – INSERM / Université Paris Cité
###Speaker: Niklas Korsbo, Ph.D. (he/him/his) – DeepPumas, Pumas-AI Inc.
### he/him/hisSpeaker: Kapil Gadkar, PhD – Genentech
###